We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal judge has affirmed UCB’s patent for Vimpat, blocking efforts by several drugmakers to market generic versions of the epilepsy drug. Read More
Juno Therapeutics has been sued in a class-action lawsuit alleging that the company violated federal securities law by failing to disclose a death during a clinical trial. Read More
The FDA has released a public notification advising consumers not to purchase or use a weight loss and energy supplement called Natural Eruption. Read More
To shed light on the regulatory requirements for the development of co-crystals, the FDA is offering drugmakers submitting ANDAs and NDAs a clearer definition of co-crystals that no longer denotes them as an in-process material. Read More
Almost a year after Bayer settled pay-for-delay allegations involving its antibiotic Cipro, Allergan and Sanofi units have struck deals to resolve lingering Cipro claims in ongoing class action litigation, agreeing to pony up $100 million. Read More